|
Stroke Treatment May Get Big Boost From Blood Flow
Discovery
Sept. 13, 2004 - There may be new treatments for
stroke, migraine, Alzheimers and other brain disorders that plague
senior citizens, thanks to the discovery of a mechanism for regulating
brain blood flow made by researchers at the University of British
Columbia.
|
This discovery will serve as a
gateway to new treatments and is of fundamental importance in
understanding how the brain regulates blood flow, says Dr.
Bruce McManus, Scientific Director of the Institute of
Circulatory and Respiratory Health of the Canadian Institutes of
Health Research (CIHR).
This powerful research gives us new
targets against which to develop a new generation of drugs to
minimize stroke damage to the brain, adds Dr. Antoine Hakim,
CEO and Scientific Director of the Canadian Stroke Network. |
|
Scientists found that astrocytes -- cells that
surround nerve cells and all blood vessels in the brain -- have a
primary role in regulating blood flow within the brain, and hold promise
as a target for new therapies.
The findings of the two-year study funded by the
Canadian Institutes of Health Research (CIHR) and the Canadian Stroke
Network were published this week in Nature by UBC post-doctoral fellow
Sean Mulligan and Brian MacVicar, a professor in the Brain Research
Centre and the Dept. of Psychiatry at UBC and an investigator with the
Vancouver Coastal Health Research Institute (VCHRI).
Using a new technique that they developed to study
brain blood flow, Mulligan and MacVicar found that a rise of calcium
within the astrocytes instructs the blood vessels to constrict, which
alters blood flow.
Brain blood flow supplies energy for brain
activities. Vessel contraction and dilation is a normal part of brain
functioning, however, improperly regulated flow can result in brain
disorder or damage. Calcium flow in the brain is not influenced by diet.
This is an exciting find because it gives us a new
site to investigate, says MacVicar, Canada Research Chair in
Neuroscience. This discovery highlights the complex communication
between astrocytes and blood vessels, and research can now be focused on
understanding and controlling these communication pathways.
The discovery that astrocytes cause constriction
upsets earlier theories that astrocytes might cause vessels to dilate,
he adds.
Next steps in the research include determining how
to block the calcium in astrocytes to reduce damage caused by inadequate
brain blood flow. MacVicar estimates treatments may be available in five
to 10 years.
Every year, 50,000 Canadians suffer a stroke, or
"brain attack." Another 300,000 people are living with the consequences
of stroke, which is the leading cause of adult disability in Canada.
Stroke is the third leading cause of death in the
United States. Each year, about 700,000 people experience a new or
recurrent stroke. About 500,000 of these are first attacks, and 200,000
are recurrent. Stroke accounted for more than one of every 15 deaths in
the country in 2001.
The Brain Research Centre, located at UBC Hospital,
comprises more than 150 investigators with multidisciplinary expertise
in neuroscience research ranging from the test tube, to the bedside, to
industrial spin-offs.
VCHRI is a joint venture between UBC and Vancouver
Coastal Health that promotes development of new researchers and research
activity.
CIHR is Canada's premier agency for health
research. Its objective is to excel, according to internationally
accepted standards of scientific excellence, in the creation of new
knowledge and its translation into improved health for Canadians, more
effective health services and products and a strengthened health care
system.
The Canadian Stroke Network includes more than 100
of Canada's leading scientists and clinicians from 24 universities who
work collaboratively on various aspects of stroke. The Network, which is
headquartered at the University of Ottawa, also includes partners from
industry, the non-profit sector, provincial and federal governments
Canada Research Chairs are federally funded research positions that are
the centerpiece of a national strategy to make Canada one of the world's
top five countries for research and development. |